BACKGROUND: American Indian and Alaska Native (AI/AN) men experience lower incidence of prostate cancer than other race/ethnic populations in the US, but racial misclassification of AI/AN men threatens the validity of these estimates. To the authors' knowledge, little is known concerning prostate-specific antigen (PSA) testing in AI/AN men. METHODS: The authors linked cancer registry data with Indian Health Service enrollment records to improve race classification. Analyses comparing cancer incidence rates and stage at diagnosis for AI/AN and non-Hispanic white (NHW) men for 6 geographic regions focused on counties known to have less race misclassification. The authors also used Behavioral Risk Factors Surveillance System data to characterize PSA testing in AI/AN men. RESULTS: Prostate cancer incidence rates were generally lower in AI/AN than in NHW men for all regions combined (rate ratio of 0.68). However, regional variation was noted among AI/AN men, with incidence rates (per 100,000 population) ranging from 65.7 in the Southwest to 174.5 on the Northern Plains. The rate of distant stage disease was somewhat higher among AI/AN (7.8) than NHW (6.2) men. Nationally, AI/AN men were less likely than NHW men to have undergone recent PSA testing (48.4% vs 58.0%), with prominent regional variation in screening rates noted. CONCLUSIONS: Prostate cancer incidence rates and the proportion of men with recent PSA testing were lower for AI/AN men than for NHW men. However, incident rates and rate of distant stage varied by region more for AI/AN than for NHW. Further research is needed among AI/AN men to evaluate strategies for better understanding the causes of the regional variation in prostate cancer incidence.
BACKGROUND: American Indian and Alaska Native (AI/AN) men experience lower incidence of prostate cancer than other race/ethnic populations in the US, but racial misclassification of AI/AN men threatens the validity of these estimates. To the authors' knowledge, little is known concerning prostate-specific antigen (PSA) testing in AI/AN men. METHODS: The authors linked cancer registry data with Indian Health Service enrollment records to improve race classification. Analyses comparing cancer incidence rates and stage at diagnosis for AI/AN and non-Hispanic white (NHW) men for 6 geographic regions focused on counties known to have less race misclassification. The authors also used Behavioral Risk Factors Surveillance System data to characterize PSA testing in AI/AN men. RESULTS:Prostate cancer incidence rates were generally lower in AI/AN than in NHW men for all regions combined (rate ratio of 0.68). However, regional variation was noted among AI/AN men, with incidence rates (per 100,000 population) ranging from 65.7 in the Southwest to 174.5 on the Northern Plains. The rate of distant stage disease was somewhat higher among AI/AN (7.8) than NHW (6.2) men. Nationally, AI/AN men were less likely than NHW men to have undergone recent PSA testing (48.4% vs 58.0%), with prominent regional variation in screening rates noted. CONCLUSIONS:Prostate cancer incidence rates and the proportion of men with recent PSA testing were lower for AI/AN men than for NHW men. However, incident rates and rate of distant stage varied by region more for AI/AN than for NHW. Further research is needed among AI/AN men to evaluate strategies for better understanding the causes of the regional variation in prostate cancer incidence.
Authors: Richard M Hoffman; Jun Li; Jeffrey A Henderson; Umed A Ajani; Charles Wiggins Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: Stephanie C Melkonian; Melissa A Jim; Donald Haverkamp; Charles L Wiggins; Jeffrey McCollum; Mary C White; Judith S Kaur; David K Espey Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-10 Impact factor: 4.254
Authors: Cynthia So; Katharine A Kirby; Kala Mehta; Richard M Hoffman; Adam A Powell; Stephen J Freedland; Brenda Sirovich; Elizabeth M Yano; Louise C Walter Journal: J Gen Intern Med Date: 2011-12-17 Impact factor: 5.128
Authors: Sydney A Martinez; Amanda E Janitz; Julie Erb-Alvarez; Dana S Mowls; Janis E Campbell; Tom Anderson Journal: J Okla State Med Assoc Date: 2016 Jul-Aug
Authors: John F Scoggins; Catherine R Fedorenko; Sara M A Donahue; Dedra Buchwald; David K Blough; Scott D Ramsey Journal: J Rural Health Date: 2011-03-31 Impact factor: 4.333
Authors: Janis E Campbell; Sydney A Martinez; Amanda E Janitz; Anne E Pate; Julie Erb-Alvarez; David F Wharton; David Gahn; Vicki L Tall; Cuyler Snider; Tom Anderson; Michael Peercy Journal: J Okla State Med Assoc Date: 2014-03
Authors: Linda Burhansstipanov; Linda U Krebs; Mark B Dignan; Kate Jones; Lisa D Harjo; Shinobu Watanabe-Galloway; Daniel G Petereit; Noel L Pingatore; Debra Isham Journal: J Cancer Educ Date: 2014-09 Impact factor: 2.037
Authors: Scott V Adams; Andrea N Burnett-Hartman; Andrew Karnopp; Aasthaa Bansal; Stacey A Cohen; Victoria Warren-Mears; Scott D Ramsey Journal: Am J Prev Med Date: 2016-03-24 Impact factor: 5.043